FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to chemical-pharmaceutical industry and deals with antituberculosis medication active with respect of drug-resistant strains of tuberculosis mycobacteria. Medication of synergic action contains antituberculosis chemical preparation - isoniaside and silver nanoparticles as potentiating agent, enhancing action of chemical preparation.
EFFECT: invention possesses ability to inhibit drug0resistant strains of tuberculosis mycobacteria and can be used for creation of novel medications for treatment of drug-resistant tuberculosis.
1 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACOLOGICAL COMPOSITION WITH ANTI-TUBERCULOSIS ACTION | 2008 |
|
RU2412715C2 |
METHOD FOR PREPARING ANTI-TUBERCULOSIS DRUG | 2010 |
|
RU2452498C2 |
PROPHYLACTIC AGENT FOR SKIN WITH ANTITUBERCULOUS EFFECT | 2009 |
|
RU2409367C2 |
IMMUNOSTIMULATING COMPOSITION | 2010 |
|
RU2424820C1 |
CULTURE MEDIUM FOR DETERMINING DRUG SUSCEPTIBILITY OF M tuberculosis TO MAIN ANTI-TUBERCULOSIS DRUGS | 2010 |
|
RU2470071C2 |
PHARMACOLOGICAL AGENT POSSESSING ANTITUBERCULOSIS ACTIVITY | 2011 |
|
RU2469711C1 |
BROTH FOR ACCELERATED DETERMINATION OF TUBERCULOSIS MYCOBACTERIUM DRUG RESISTANCE | 2003 |
|
RU2252260C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
METHOD FOR DIAGNOSIS OF SENSITIVITY OF MYCOBACTERIUM TUBERCULOSIS TO ANTITUBERCULOSIS PREPARATIONS | 2005 |
|
RU2315113C2 |
METHOD OF TREATING PULMONARY TUBERCULOSIS | 2011 |
|
RU2452495C1 |
Authors
Dates
2010-11-10—Published
2008-10-28—Filed